Edward Smith F.'s most recent trade in Benitec Biopharma Inc was a trade of 35,000 Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Benitec Biopharma Inc | Edward F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 35,000 | 35,000 | - | - | Options (right to buy) | |
| Benitec Biopharma Inc | Edward Smith F. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 35,000 | 35,000 | - | - | Options (right to buy) | |
| Marinus Pharmaceuticals Inc | Edward F. Smith | Former VP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 09 Mar 2021 | 40,356 | 13,288 (0%) | 0% | 17.8 | 718,337 | Common Stock |
| Marinus Pharmaceuticals Inc | Edward F. Smith | Former VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 09 Mar 2021 | 35,927 | 53,644 (0%) | 0% | 4.2 | 149,456 | Common Stock |
| Marinus Pharmaceuticals Inc | Edward F. Smith | Former VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 35,927 | 0 | - | - | Stock Option (right to buy) | |
| Benitec Biopharma Inc | Edward F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 23,601 | 23,601 | - | - | Options (right to buy) |